LAST PRICE - AT THE CLOSE
DRUG is DOWN -16% since the begininning of the year
DRUG is DOWN -4% BELOW 20 day SMA
DRUG is DOWN -10% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.536582
EARNINGS MOMENTUM: YES
0.14% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
![]() |
THE STOCK IS 46.8% AWAY FROM ALL-TIME HIGHS OF $123.75 |
![]() |
DRUG IS DOWN -16% SINCE THE BEGINNING OF THE YEAR |
![]() |
DRUG IS UP 165% OVER THE PAST 12 MONTHS |
![]() |
DRUG IS DOWN -24% OVER THE PAST 1 MONTH |
![]() |
6% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
![]() |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
![]() |
DRUG moved up 0 in the previous minute |
![]() |
DRUG is up 0.02 over the last hour |
![]() |
DRUG is up 10.6% over the last 5 days |
![]() |
DRUG is 5.8 above its 8 day SMA |
| $63.00 | ![]() DAY |
$66.18 |
| $63.29 | ![]() PREVIOUS DAY |
$67.14 |
| $59.00 | ![]() WEEK |
$68.54 |
| $56.47 | ![]() MONTH |
$90.67 |
| $0.94 | ![]() ![]() YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on
DRUG is mentioned N/A times in an average day on